Choice of Nanovaccine Delivery Mode Has Profound Impacts on the Intralymph Node Spatiotemporal Distribution and Immunotherapy Efficacy
Open Access
- 15 August 2020
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 7 (19)
Abstract
Nanovaccines have attracted booming interests in vaccinology studies, but the profound impacts of their delivery mode on immune response remain unrealized. Herein, immunostimulatory CpG‐modified tumor‐derived nanovesicles (CNVs) are used as a nanovaccine testbed to initially evaluate the impacts of three distinct delivery modes, including mono‐pulse CNVs, staggered‐pulse CNVs, and gel‐confined CNVs. Fundamentally, delivery mode has enormous impacts on the immunomodulatory effects, altering the spatiotemporal distribution of nanovaccine residence and dendritic cell–T cell interaction in lymph nodes, and finally affecting subsequent T cell‐mediated immune performance. As a result, the gel‐confined delivery mode offers the best therapeutic performance in multiple tumor models. When extending evaluation to examine how the various delivery modes impact the performance of liposome‐based nanovaccines, similar trends in intralymph node distribution and antitumor effect are observed. This work provides a strong empirical foundation that nanovaccine researchers should position delivery mode near the top of their considerations for the experimental design, which should speed up nanovaccine development and facilitate efficient selection of appropriate delivery modes in the clinic.Keywords
Funding Information
- National Natural Science Foundation of China (21821005)
- Chinese Academy of Sciences (XDB29040303)
- National Basic Research Program of China (2017YFA0207900)
- Natural Science Foundation of Beijing Municipality (2202056)
- National Natural Science Foundation of China (21821005)
- Chinese Academy of Sciences (XDB29040303)
- Natural Science Foundation of Beijing Municipality (2202056)
This publication has 59 references indexed in Scilit:
- In Situ Regulation of DC Subsets and T Cells Mediates Tumor Regression in MiceScience Translational Medicine, 2009
- Heterologous prime–boost vaccinationCurrent Opinion in Immunology, 2009
- Infection-mimicking materials to program dendritic cells in situNature Materials, 2009
- Nanoparticles target distinct dendritic cell populations according to their sizeEuropean Journal of Immunology, 2008
- Exploiting lymphatic transport and complement activation in nanoparticle vaccinesNature Biotechnology, 2007
- A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery systemBiomaterials, 2007
- In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticlesJournal of Controlled Release, 2006
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Regulation of Dendritic Cell Migration to the Draining Lymph NodeJournal of Experimental Medicine, 2003
- Dynamic Imaging of T Cell-Dendritic Cell Interactions in Lymph NodesScience, 2002